Pharmaceuticals & Biotechnology

ZIM LABORATORIES LTD

ISIN: INE518E01015 · Data as of Jul 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
1
vs Last Month
0 funds
Total Value
₹7.13 Cr
Avg Weight
0.46%
New Entries
0
Exits
0
Top Holder
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 0.46%
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
Small Cap Rank #1933
₹432 Cr
Avg Mkt Cap · Jan-Jun 2023 (3yr ago)
→
₹428 Cr
Avg Mkt Cap · Jan-Jun 2026 (latest)
-0.9%
3yr change
SEBI · AMFI Market Cap List
📋 What Changed This Month ZIM LABORATORIES LTD is currently held by 1 active mutual funds with total exposure of ₹7.13 Cr. This month 0 funds entered and 0 funds exited. Tata India Pharma & Healthcare Fund-Direct Plan-Growth has the highest allocation at 0.46%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 2 Months?

Month Funds AUM (Cr) AMCs Status
Jul 2026 REFERENCE 1 ₹7 49 / 49 ✅ Complete
Jun 2026 1 ₹7 49 / 49 ✅ Complete

📌 Portfolio changes below are based on Jul 2026 data — the most complete month with 49 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Jul 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

▲ New Entries (0)
No new entries this month
▼ Exits (0)
No exits this month
↑ Increased (0)
No increases this month
↓ Decreased (1)
Tata India Pharma & Healthcare Fund-Direct Plan-Growth -0.03%
By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Equity 1 0.46%
All Holdings

Which 1 Active Funds Hold ZIM LABORATORIES LTD?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Tata Mutual Fund 		Equity 0.46% ₹7.13 Cr -0.03%
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.